Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer (2003)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM
- Unidade: FM
- Subjects: NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: American Society of Clinical Oncology
- Volume/Número/Paginação/Ano: v. 22, 2003
- Conference titles: Annual meeting of the American Society of Clinical Oncology
-
ABNT
CASTRO, G. et al. Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 dez. 2025. , 2003 -
APA
Castro, G., Diz, M. D. E., Siqueira, S. A. C., Carvalho, F. M., Folgueira, M. A. A. K., Snitcovsky, I. M., et al. (2003). Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Castro G, Diz MDE, Siqueira SAC, Carvalho FM, Folgueira MAAK, Snitcovsky IM, Brentani MM, Federico MHH. Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer. American Society of Clinical Oncology. 2003 ; 22[citado 2025 dez. 29 ] -
Vancouver
Castro G, Diz MDE, Siqueira SAC, Carvalho FM, Folgueira MAAK, Snitcovsky IM, Brentani MM, Federico MHH. Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer. American Society of Clinical Oncology. 2003 ; 22[citado 2025 dez. 29 ] - Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Flow-cytometric DNA analysis and hormonal receptor status in brazilian breast cancer patients
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Thymocyte subpopulations and clonality in myasthenia gravis
- Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
